Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)
NCT06434350
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Advanced Bladder Cancer
Interventions
DRUG:
Enfortumab Vedotin
RADIATION:
Radiation Therapy
Sponsor
M.D. Anderson Cancer Center